Asia-Pacific Graves’ disease Market Growth, Size, Share, Industry Report and Forecast 2019-2025
Asia-Pacific Graves’ diseases market is growing at a CAGR of around 5.5% during the forecast period. The region has a potential market for the Grave’s disease market due to the increasing prevalence of diabetes in the emerging economies of the region, especially in China. Diabetic patients, in particular, type-1 diabetic patients, are more prone to develop Grave’s disease. Furthermore, emerging healthcare infrastructure coupled with increasing disposable income is also expected to drive the adoption of treatment of Grave’s disease, in turn affecting the Asia-Pacific Graves’ disease market growth.
To Request a Sample of our Report on Asia-Pacific
Graves’ disease Market:
https://www.omrglobal.com/request-sample/asia-pacific-graves-disease-market
According to IDF, in 2017, there
were around 1.1, 3.6, and 10.3 million numbers of people, who were diagnosed
with diabetes, in Australia, South Korea, and Indonesia respectively. These
figures are expected to reach around 1.5, 4.6, and 16.2 million, by 2040, in
Australia, South Korea, and Indonesia respectively. The prevalence rate of
diabetes in Australia and Indonesia are around 5.1% and 6.3% which increases
the probability of person acquiring Grave’s disease and thus, promises the
significant market for the Grave’s disease in the region. Whereas, China
accounts for nearly 121 million individuals live with diabetes and around 74
million people living with diabetes in India. The development of personalized
medicines such as the introduction of traditional Chinese medicine (TCM)
further propels the growth of the Asia-Pacific Graves’ disease market during
the forecast period.
Despite an economic slowdown in
several countries of the region such as India, the increasing public healthcare
programs including the increasing private wealth are further expected to propel
the healthcare spending of Asia-Pacific by an annual average of 6.6% from 2015
to 2019. Asia-Pacific is growing at a modest rate in the market due to various
factors such as rising healthcare spending, improving infrastructure, and
rising standards of living. China, India, Japan, Australia, Korea, and Taiwan
are the key countries growing at a significant rate in the Asia-Pacific Graves’
diseases market.
(Get 15% Discount on Buying this Report)
A
full Report Asia-Pacific Graves’ disease Market is Available @ https://www.omrglobal.com/industry-reports/asia-pacific-graves-disease-market
Asia-Pacific Graves’ disease Market Segmentation
By Diagnosis
·
Ultrasound
·
Imaging Tests
·
Radioactive Iodine Uptake
·
Blood Sample
By Treatment
·
Anti- Thyroid Medication
·
Radioactive Iodine Therapy
·
Surgery
Regional Analysis
·
China
·
India
·
Japan
Rest of Asia-Pacific
Company Profiles
·
Abbott Laboratories Inc.
·
Allergan PLC
·
Eli Lilly and Co.
·
GlaxoSmithKline PLC
·
Johnson & Johnson
·
Macleods Pharmaceuticals Ltd.
·
Merck & Co. Inc.
·
Mylan NV
·
Novartis International AG
·
Pfizer Inc.
·
Sanofi SA
·
Takeda Pharmaceutical Co. Ltd.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment